Martin Shkreli, the notorious pharmaceutical boss who gained rights to a $13.50 malaria medication and then promptly raised its price to $750, has become the new CEO of cancer-treatment developer KaloBios, after buying out the company at fire-sale prices. Read Full Article at RT.com чинара президент корпорації упражнения
Немає коментарів:
Дописати коментар